MicroRNAs as Indicators of Malignancy in Pancreatic Ductal Adenocarcinoma (PDAC) and Cystic Pancreatic Lesions
The dysregulation of microRNAs has recently been associated with cancer development and progression in pancreatic ductal adenocarcinoma (PDAC) and cystic pancreatic lesions. In solid pancreatic tumor tissue, the dysregulation of miR-146, miR-196a/b, miR-198, miR-217, miR-409, and miR-490, as well as...
Main Authors: | Christian Prinz, Leonard Fehring, Robin Frese |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-08-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/11/15/2374 |
Similar Items
-
Clinically impactful metabolic subtypes of pancreatic ductal adenocarcinoma (PDAC)
by: Jannat Pervin, et al.
Published: (2023-10-01) -
Regulatory role of RNA modifications in the treatment of pancreatic ductal adenocarcinoma (PDAC)
by: Hao Chen, et al.
Published: (2023-11-01) -
Pancreatic ductal adenocarcinoma arising from the pancreatic parenchyma compressed by a huge pancreatic lipoma: a case report
by: Seiji Nakahara, et al.
Published: (2023-08-01) -
WDR79 promotes aerobic glycolysis of pancreatic ductal adenocarcinoma (PDAC) by the suppression of SIRT4
by: Yin Wenke, et al.
Published: (2023-01-01) -
Nickel’s Role in Pancreatic Ductal Adenocarcinoma: Potential Involvement of microRNAs
by: Maria Mortoglou, et al.
Published: (2022-03-01)